NuCana (NCNA) Current Assets (2016 - 2025)
NuCana (NCNA) reported Current Assets of $35.7 million for Q4 2025, up 126.97% on a YoY basis from $15.7 million in Q4 2024, and down 11.26% sequentially from $40.3 million in Q3 2025.
NuCana (NCNA) Current Assets (2016 - 2025) Analysis & Trends
NuCana (NCNA) has 10 years of Current Assets data on file, last reported at $35.7 million in Q4 2025.
- For the quarter ending Q4 2025, Current Assets rose 126.97% year-over-year to $35.7 million; the trailing twelve-month figure through Dec 2025 stood at $35.7 million (up 126.97% YoY), and the FY2025 full-year result was $35.4 million, up 125.9% from the prior year.
- Current Assets slipped to $35.7 million in Q4 2025, from $40.3 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $131.0 million in Q1 2021 to a low of $11.5 million in Q1 2025.
- A 5-year average of $56.4 million and a median of $43.8 million in 2023 frame the typical range for Current Assets.
- Peak annual rise in Current Assets reached 126.97% in 2025, while the deepest fall reached 58.95% in 2025.
- Tracing NCNA's Current Assets over 5 years: stood at $96.5 million in 2021, then slumped by 33.27% to $64.4 million in 2022, then sank by 51.79% to $31.1 million in 2023, then plunged by 49.3% to $15.7 million in 2024, then surged by 126.97% to $35.7 million in 2025.
- Business Quant data shows NCNA's Current Assets at $35.7 million in Q4 2025, $40.3 million in Q3 2025, and $18.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 4.22 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.73 Mn |
| Sep 30, 2025 | 40.26 Mn |
| Jun 30, 2025 | 18.32 Mn |
| Mar 31, 2025 | 11.48 Mn |
| Dec 31, 2024 | 15.74 Mn |
| Sep 30, 2024 | 21.93 Mn |
| Jun 30, 2024 | 21.89 Mn |
| Mar 31, 2024 | 27.97 Mn |
| Dec 31, 2023 | 31.05 Mn |
| Sep 30, 2023 | 38.82 Mn |
| Jun 30, 2023 | 47.41 Mn |
| Mar 31, 2023 | 55.16 Mn |
| Dec 31, 2022 | 64.42 Mn |
| Sep 30, 2022 | 73.57 Mn |
| Jun 30, 2022 | 76.65 Mn |
| Mar 31, 2022 | 87.98 Mn |
| Dec 31, 2021 | 96.54 Mn |
| Sep 30, 2021 | 112.08 Mn |
| Jun 30, 2021 | 120.81 Mn |
| Mar 31, 2021 | 130.95 Mn |